AssetMark Inc Portfolio holdings
AssetMark runs an investment platform that financial advisors use to build portfolios for their clients and to handle the technology behind them. Financial advisor Ron Cordes and his partners started it in 1996 to solve a problem in their own practice, which was fitting investment strategies into a fee-based, fiduciary business. Cordes and his partners sold the company to Genworth Financial in 2006, and it operated under Genworth names until it took the AssetMark name in 2013. Advisors can place clients in model portfolios of mutual funds and ETFs, and AssetMark also runs its own mutual funds, the GuideMark and GuidePath families. Private equity firm GTCR owns AssetMark through a holding company, after earlier owners that included Aquiline Capital Partners and Genstar Capital.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra S&P500
SSO
|
+$361M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$279M |
| 3 |
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
|
+$226M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$132M |
| 5 |
Edison International
EIX
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$428M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$207M |
| 3 |
U.S. Core Equity 2 Portfolio ETF Class Shares
DFAC
|
+$119M |
| 4 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$117M |
| 5 |
AT&T
T
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.1% |
| 2 | Technology | 12.54% |
| 3 | Financials | 4.9% |
| 4 | Communication Services | 4.81% |
| 5 | Healthcare | 3.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3401
ADMA Biologics
ADMA
$2.35B
| $512 | ﹤0.01% |
+51
| New | +$472 |
2026 Q3
0 quarters
|
|
3402
Gencor Industries
GENC
$257M
| $512 | ﹤0.01% |
30
| – | – |
2024 Q3
8 quarters
|
|
3403
iShares MSCI France ETF
EWQ
$360M
| $511 | ﹤0.01% |
+12
| New | +$547 |
2026 Q3
0 quarters
|
|
3404
Franklin Municipal High Yield ETF
FTMH
$548M
| $510 | ﹤0.01% |
47
-176
| -79% | -$2.02K |
2026 Q2
1 quarter
|
|
3405
AmpliTech
AMPG
$74.7M
| $506 | ﹤0.01% |
161
+61
| +61% | +$283 |
2026 Q2
1 quarter
|
|
3406
Arcos Dorados Holdings
ARCO
$1.49B
| $501 | ﹤0.01% |
70
-500
| -88% | -$4K |
2025 Q4
3 quarters
|
|
3407
Oruka Therapeutics
ORKA
$6.71B
| $500 | ﹤0.01% |
+6
| New | +$565 |
2026 Q3
0 quarters
|
|
3408
Orion Office REIT
ONL
$141M
| $498 | ﹤0.01% |
200
| – | – |
2026 Q2
1 quarter
|
|
3409
ProShares UltraShort Silver
ZSL
$70.5M
| $498 | ﹤0.01% |
+18
| New | +$481 |
2026 Q3
0 quarters
|
|
3410
Invesco Leisure and Entertainment ETF
PEJ
$374M
| $496 | ﹤0.01% |
8
| – | – |
2026 Q2
1 quarter
|
|
3411
IHS Holding
IHS
$2.87B
| $493 | ﹤0.01% |
59
| – | – |
2025 Q2
5 quarters
|
|
3412
AngioDynamics
ANGO
$515M
| $492 | ﹤0.01% |
32
+16
| +100% | +$238 |
2024 Q3
8 quarters
|
|
3413
Lumexa Imaging Holdings
LMRI
$1.26B
| $492 | ﹤0.01% |
48
| – | – |
2025 Q4
3 quarters
|
|
3414
Centerspace
CSR
$1B
| $490 | ﹤0.01% |
+9
| New | +$498 |
2026 Q3
0 quarters
|
|
3415
Hilltop Holdings
HTH
$2.14B
| $490 | ﹤0.01% |
+13
| New | +$504 |
2026 Q3
0 quarters
|
|
3416
Aurora
AUR
$8.24B
| $488 | ﹤0.01% |
88
| – | – |
2025 Q2
5 quarters
|
|
3417
Enlight Renewable Energy
ENLT
$9.46B
| $486 | ﹤0.01% |
7
| – | – |
2025 Q2
5 quarters
|
|
3418
Adtran
ADTN
$385M
| $485 | ﹤0.01% |
71
-50
| -41% | -$444 |
2025 Q2
5 quarters
|
|
3419
Abacus Global Management
ABX
$885M
| $484 | ﹤0.01% |
60
| – | – |
2024 Q2
9 quarters
|
|
3420
Vericel Corp
VCEL
$2.33B
| $482 | ﹤0.01% |
12
-3
| -20% | -$130 |
2024 Q2
9 quarters
|
|
3421
Eaton Vance Enhanced Equity Income Fund
EOI
$797M
| $477 | ﹤0.01% |
24
| – | – |
2025 Q2
5 quarters
|
|
3422
CCC Intelligent Solutions
CCC
$4.55B
| $473 | ﹤0.01% |
+71
| New | +$467 |
2026 Q3
0 quarters
|
|
3423
ALPS Emerging Sector Dividend Dogs ETF
EDOG
$21.7M
| $473 | ﹤0.01% |
+20
| New | +$492 |
2026 Q3
0 quarters
|
|
3424
Clough Global Opportunities Fund
GLO
$234M
| $470 | ﹤0.01% |
88
| – | – |
2024 Q1
10 quarters
|
|
3425
Syndax Pharmaceuticals
SNDX
$933M
| $470 | ﹤0.01% |
25
-15
| -38% | -$303 |
2025 Q3
4 quarters
|
|
Similar funds
AssetMark Inc's Q3 2026 Portfolio in Review
As of Q3 2026, AssetMark Inc held 3,948 positions worth $59.5B, up 2.2% from $58.2B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
AssetMark Inc's Q3 2026 filing shows 390 new, 1,759 increased, 1,017 reduced and 175 closed positions. Its largest new stake was Invesco S&P 500 QVM Multi-factor ETF: 2,240,350 shares worth $101M. The largest sale was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $428M.
By sector, the portfolio is most concentrated in Miscellaneous at 64% of assets, down from 65% a quarter earlier, followed by Technology and Financials.
- AssetMark Inc's largest Q3 2026 buy was Invesco S&P 500 QVM Multi-factor ETF: 2,240,350 shares worth $101M.
- AssetMark Inc added most to ProShares Ultra S&P500 in Q3 2026, an estimated $361M increase.
- AssetMark Inc's biggest Q3 2026 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $428M.
- AssetMark Inc fully exited Taylor Morrison in Q3 2026, selling an estimated $11.9M.
- AssetMark Inc's ten largest holdings make up 29% of its $59.5B portfolio in Q3 2026.
- AssetMark Inc opened 390 new positions and closed 175 in Q3 2026.
- AssetMark Inc's portfolio value rose 2.2% quarter-over-quarter to $59.5B.
Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.